Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brucea javanica oil for maintenance treatment of advanced gastric cancer
ChiCTR2000028933Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Jan 2020
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of brucea javanica oil in gastric cancer (GC) (2 arms), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Primary endpoint: 1-year survival rate. Started Jan 2020; status: recruiting.
02
Drugs
brucea javanica oil
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on ChiCTR2000028933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028933.